Immuneering Corp

IMRX

Company Profile

  • Business description

    Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

  • Contact

    245 Main Street
    Second Floor
    CambridgeMA02142
    USA

    T: +1 617 500-8080

    https://www.immuneering.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    54

Stocks News & Analysis

stocks

BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs

We plan to raise our fair value estimate of BlackRock stock.
stocks

Our view of ANZ’s strategic plan

Trying to please customers and shareholders with a simpler and leaner bank.
stocks

Perplexing buyback from overvalued ASX share

Earnings continue to grow but investor expectations are too high.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,271.605.50-0.06%
CAC 407,919.6214.64-0.18%
DAX 4024,236.94150.99-0.62%
Dow JONES (US)46,270.46202.880.44%
FTSE 1009,452.779.900.10%
HKSE25,714.89273.541.08%
NASDAQ22,521.70172.91-0.76%
Nikkei 22547,261.31413.990.88%
NZX 50 Index13,311.7034.710.26%
S&P 5006,644.3110.41-0.16%
S&P/ASX 2008,964.304.40-0.05%
SSE Composite Index3,864.930.30-0.01%

Market Movers